Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Clinical trial NCT02058563 · COMPLETED

Trial details

NCT number: NCT02058563
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rubella Mumps Measles

Start date: 2014-07-01
Primary completion: 2015-05-24
Enrollment: 996

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.